Intuitive Surgical, Inc.(ISRG)NASDAQ
Company Profile & Information
Company Profile
Business overview, scale, and footprint
Business Overview
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Insider Transactions
Open-market activity and option exercises
Insider Activity Summary
Insider trading activity for Intuitive Surgical, Inc. (ISRG) over the last 3 months consists of 166 total transactions. Among these, company executives and board members conducted 166 buys (totaling 785,986 shares) and 0 sells (totaling 0 shares). This activity resulted in a net change of 785,986 shares, reflecting net buying interest with an estimated net acquisitions value of $125.32M.
166 insider transactions found. Showing 10 of 166 transactions.
| Insider Name | Relation to Company | Shares Changed | Price | Transaction Date |
|---|---|---|---|---|
| BROSIUS MARK PRESTON | Officer | 154 | $0.06 | Aug 21, 2026 |
| BROSIUS MARK PRESTON | Officer | 231 | $0.09 | Aug 19, 2026 |
| GUTHART GARY S | Director | 10,000 | $4.00 | Aug 11, 2026 |
| LADD AMY L | Director | 472 | $0.18 | Aug 11, 2026 |
| LOEB GARY | Officer | 400 | $0.15 | Aug 10, 2026 |
| BROSIUS MARK PRESTON | Officer | 56 | $19539.00 | Jul 31, 2026 |
| BROSIUS MARK PRESTON | Officer | 84 | $29954.00 | Jul 29, 2026 |
| ROSA DAVID J | Chief Executive Officer | 1,910 | $N/A | Jul 10, 2026 |
| BROSIUS MARK PRESTON | Officer | 48 | $19833.00 | Jun 12, 2026 |
| BROSIUS MARK PRESTON | Officer | 69 | $29104.00 | Jun 10, 2026 |
Explore More Analysis for ISRG
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.